Risk and outcome of multidrug-resistant tuberculosis: Vitamin D receptor polymorphisms and serum 25(OH)D

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 11, 2012, Pages 1522-1528

  Rathored, J ^a   Sharma, Surendra Kumar ^a   Singh, B ^a   Banavaliker, J N ^b   Sreenivas, V ^a   Srivastava, A K ^a   Mohan, A ^c   Sachan, A ^c   Harinarayan, C V ^c   Goswami, R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Rajan Babu Institute of Pulmonary Medicine and Tuberculosis   (India)

^c SRI VENKATESWARA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Drug susceptible TB; Intact parathyroid hormone; Serum calcium; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; VITAMIN D RECEPTOR;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BACTERIAL LOAD; BODY MASS; BSM1 GENE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; FOK1 GENE; GENE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HUMAN; INDIA; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SPUTUM SMEAR; TAQ1 GENE; TREATMENT RESPONSE; VITAMIN BLOOD LEVEL; VITAMIN D RECEPTOR GENE;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; RECEPTORS, CALCITRIOL; SEVERITY OF ILLNESS INDEX; SPUTUM; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84867203962     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0122     Document Type: Article

References (28)

1. World Health Organization. Global tuberculosis control 2011. WHO/HTM/TB/2011.16. Geneva, Switzerland: WHO, 2011.
2. Caminero J A, Sotgiu G, Zumla A, Migliori G B. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis 2010; 10: 621-629.
3. Plum L A, DeLuca H F. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov 2010; 9: 941-955.
4. Reddy Vanga S, Good M, Howard P A, Vacek J L. Role of vitamin D in cardiovascular health. Am J Cardiol 2010; 106: 798-805.
5. Shen L H, Zhang X M, Su D J, et al. Association of vitamin D binding protein variants with susceptibility to chronic obstructive pulmonary disease. J Int Med Res 2010; 38: 1093-1098.
6. Li H, Stampfer M J, Hollis J B, et al. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med 2007; 4: e103.
7. Fox J, Peters B, Prakash M, Arribas J, Hill A, Moecklinghoff C. Improvement in vitamin D deficiency following antiretroviral regime change: results from the MONET trial. AIDS Res Hum Retroviruses 2011; 27: 29-34.
8. Nnoaham K E, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008; 37: 113-119. (Pubitemid 351228619)
9. Davies P D, Brown R C, Woodhead J S. Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax 1985; 40: 187-190. (Pubitemid 15108303)
10. Sita-Lumsden A, Lapthorn G, Swaminathan R, Milburn H J. Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight. Thorax 2007; 62: 1003-1007. (Pubitemid 350084502)
11. Wejse C, Gomes V F, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009; 179: 843-850.
12. Martineau A R, Timms P M, Bothamley G H, et al. High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011; 377: 242-250.
13. Gao L, Tao Y, Zhang L, Jin Q. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int J Tuberc Lung Dis 2010; 14: 15-23.
14. Bornman L, Campbell S J, Fielding K, et al. Vitamin D receptor polymorphism and susceptibility to tuberculosis in West Africa: a case-control and family study. J Infect Dis 2004; 190: 1631-1641. (Pubitemid 39411013)
15. Lombard Z, Dalton D L, Venter P A, Williams R C, Bornman L. Association of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa. Hum Immunol 2006; 67: 643-654. (Pubitemid 44205323)
16. Lewis S J, Baker I, Davey Smith G. Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk. Int J Tuberc Lung Dis 2005; 9: 1174-1177. (Pubitemid 41433810)
17. Selvaraj P, Chandra G, Kurian S M, Reetha A M, Narayanan P R. Association of vitamin D receptor gene variants of Bsm I, Apa I and Fok I polymorphisms with susceptibility or resistance to pulmonary tuberculosis. Curr Sci 2003; 84: 1564-1568. (Pubitemid 39160624)
18. Wilkinson R J, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in West London: a case-control study. Lancet 2000; 355: 618-621. (Pubitemid 30099469)
19. Babb C, van der Merwe L, Beyers N, et al. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis 2007; 87: 295-302. (Pubitemid 46951033)
20. Roth D E, Soto G, Arenas F, et al. Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis. J Infect Dis 2004; 190: 920-927. (Pubitemid 39120969)
21. Khatri G R, Frieden T R. Controlling tuberculosis in India. N Engl J Med 2002; 347: 1420-1425. (Pubitemid 35239715)
22. National Tuberculosis Association of the USA. Diagnostic standards and classification of tuberculosis. New York, NY, USA: National Tuberculosis Association, 1961.
23. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare. TB India 2010: RNTCP status report. New Delhi, India: Ministry of Health and Family Welfare, 2010.
24. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare. Revised National TB Control Programme [RNTCP]: DOTS-Plus guidelines. New Delhi, India: Ministry of Health and Family Welfare, 2010.
25. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 4th ed. WHO/HTM/TB/2009. 420. Geneva, Switzerland: WHO, 2010.
26. World Health Organization. Laboratory services in tuberculosis control. II: microscopy. WHO/TB/98.258. Geneva, Switzerland: WHO, 1998.
27. Vupputuri M R, Goswami R, Gupta N, Ray D, Tandon N, Kumar N. Prevalence and functional significance of 25-hydroxyvitamin D deficiency and vitamin D receptor gene polymorphism in Asian Indians. Am J Clin Nutr 2006; 83: 1411-1419. (Pubitemid 44713074)
28. Sasidharan P K, Rajeev E, Vijayakumari V. Tuberculosis and vitamin D deficiency. J Assoc Physicians India 2002; 50: 554-558.